SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001847903-23-000015
Filing Date
2023-01-04
Accepted
2023-01-04 19:28:15
Documents
1
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167287846191624.html 4  
1 FORM 4 wf-form4_167287846191624.xml 4 3540
  Complete submission text file 0001847903-23-000015.txt   5080
Mailing Address C/O AXOVANT SCIENCES, INC. 320 WEST 37TH STREET, 5TH FLOOR NEW YORK NY 10018
Business Address
Weinhoff Gregory M (Reporting) CIK: 0001400975 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40445 | Film No.: 23509155

Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Issuer) CIK: 0001847903 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations